Yumiko Saito

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

MR Imaging/Ultrasound Fusion-Guided Biopsy and Primary Focal Therapy for Localized Prostate Cancer.

MR Imaging/Ultrasound Fusion-Guided Biopsy and Primary Focal Therapy for Localized Prostate Cancer.

Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine

Published: June 03, 2026

Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer.

Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer.

Journal: Japanese journal of clinical oncology

Published: April 04, 2026

Triplet versus doublet therapy in patients with metastatic hormone-sensitive prostate cancer.

Triplet versus doublet therapy in patients with metastatic hormone-sensitive prostate cancer.

Journal: Scientific reports

Published: December 15, 2025

Exploratory trial of urethral submucosa injection therapy of deflux for stress urinary incontinence after radical prostatectomy.

Exploratory trial of urethral submucosa injection therapy of deflux for stress urinary incontinence after radical prostatectomy.

Journal: International journal of surgery protocols

Published: June 02, 2025

MRI-Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer.

MRI-Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer.

Journal: Prostate cancer

Published: June 01, 2025

Screening for Predictive Factors of Efficacy of Second-Generation Androgen Receptor Axis-Targeted Agents in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer.

Screening for Predictive Factors of Efficacy of Second-Generation Androgen Receptor Axis-Targeted Agents in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer.

Journal: The Prostate

Published: October 03, 2024

Identification of c-Met as a novel target of γ-glutamylcyclotransferase.

Identification of c-Met as a novel target of γ-glutamylcyclotransferase.

Journal: Scientific reports

Published: February 03, 2023

Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion.

Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion.

Journal: Scientific reports

Published: February 02, 2020

Focal salvage low-dose-rate brachytherapy for recurrent prostate cancer based on magnetic resonance imaging/transrectal ultrasound fusion biopsy technique.

Focal salvage low-dose-rate brachytherapy for recurrent prostate cancer based on magnetic resonance imaging/transrectal ultrasound fusion biopsy technique.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: July 09, 2019

Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.

Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.

Journal: Biochemical and biophysical research communications

Published: October 12, 2015

Creation and biochemical analysis of a broad-specific claudin binder.

Creation and biochemical analysis of a broad-specific claudin binder.

Journal: Biomaterials

Published: December 26, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026